Overview
Angela Gamalski is a partner in the firm’s Regulatory Department. She advises firm clients regarding a variety of trade and international regulatory and transactional matters. She works with a wide range of North American businesses, from start-ups to mid-market and publicly traded companies. Angela focuses on the automotive, aerospace, heavy industrial and medical device sectors, including automotive OEM, medical device manufacturers and companies in the defense supply chain.
Angela also serves as chair of the firm’s Corporate Transparency Act Task Force, leading firmwide policy, process and practice developments to embrace compliance with the new federal beneficial ownership reporting laws impacting all U.S. businesses. Angela is a sought after speaker and media source on this topic and has contributed to reporting in major national news outlets, including The Wall Street Journal, The New York Times and Bloomberg Law.
Clients appreciate Angela’s candor and thoughtful approach to trade compliance policy and the strategic concerns that arise from global business transactions, including navigating sanctions regimes and resolving administrative inquiries of potential export violations. She counsels clients regarding anti-bribery, anti-money laundering, sanctions and trade compliance program development, implementation, improvements and investigations. Angela is a trusted advisor in risk assessment and mitigation for supply chain and distribution chain security practices.
Angela is a frequent presenter to legal and business forums regarding developments in international trade, anti-money laundering, and export control laws.
In her free time, she enjoys exploring global cuisine, especially Cuban, Persian and eastern European restaurants.
Services
Practice Areas
Experience
Representative Matters
- Counseled clients with Anti-Money Laundering (AML) regulatory requirements and compliance responses in financing transactions.
- Counseled clients with customs and importing concerns, including Uyghur Forced Labor Prevention Act (UFLPA) holds and compliance support.
- Represented foreign acquirers and U.S. businesses before the Committee for Foreign Investment in the United States (CFIUS).
- Assisted client with export control compliance and export licensing matters, including obtaining export classification and export license from the Bureau of Industry and Security.
- Assisted clients with implementation of Foreign Corrupt Practices Act (FCPA) policies and compliance reviews.
- Provided government contract review and counseling to clients in the defense supply chain and supported government contractor registration matters.
- Counseled client regarding International Traffic in Arms Regulations (ITAR) registration requirements, defense article classifications and licensing needs.
- Led investigation of Office of Foreign Asset Control (OFAC) sanctions compliance matters for multi-national client.
Credentials
Education
- magna cum laude
- Health Law Society, President
- International Law Review, Online Managing Editor
- Health Administration
- Honors College, Highest Honors
Admissions
- Michigan
- District of Columbia
Recognition
Awards
- The Best Lawyers in America, Ones to Watch
- Recognized in the areas of:
- Corporate Law, 2021-2025
- Health Care Law, 2021-2025
- Administrative / Regulatory Law, 2023-2025
- Recognized in the areas of:
- Michigan Super Lawyers, Recognized as a Rising Star, 2023-2024
Professional & Community Involvement
State Bar of Michigan, International Law Section, Treasurer
Michigan World Trade Week annual conference, Planning Committee Member
Society of International Affairs, Member